Osteoarthritis increases the risk of inflammatory arthritis due to immune checkpoint inhibitors associated with tissue-resident memory T cells

Objective Immune checkpoint inhibitors (ICIs) have significantly advanced cancer treatment, but they can also lead to immune-related adverse events (irAEs), including inflammatory arthritis. Understanding the risk factors and underlying mechanisms of irAE pathogenesis is crucial for optimal patient...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yevgeniya Gartshteyn, Brian S Henick, Robert J Winchester, Adam Mor, Matthieu Paiola, Daniel M Portnoy, Luke Yi Hao, Shoiab Bukhari
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2025-03-01
Edice:	Journal for ImmunoTherapy of Cancer
On-line přístup:	https://jitc.bmj.com/content/13/3/e010758.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!